(Q39097045)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

1 reference

head and neck carcinoma

1 reference

1 reference

Felicity C. Kalinowski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Gregory J Goodall

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Keith M Giles

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Patrick A Candy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Michael R Epis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Priscilla M Zhang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Andrew D Redfern

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Lisa M Stuart

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Peter J Leedman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

11 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

Molecular Cancer Therapeutics

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

2541-2558

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

20 February 2020

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NG.2330

Identifiers

DOI

10.1158/1535-7163.MCT-13-0170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24026012%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference